(Q44297611)

1 December 2017

Interferon beta-1a in primary progressive multiple sclerosis (English)

1 reference

primary progressive multiple sclerosis

1 December 2017

0 references

multiple sclerosis

0 references

author name string

Siobhan M Leary

series ordinal

1

1 reference

PubMed ID

12559514

1 December 2017

Alan J Thompson

series ordinal

2

1 reference

1 December 2017

1 February 2003

1 reference

Journal of the Neurological Sciences

1 December 2017

2

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

1 December 2017

206

1 reference

1 December 2017

2

1 reference

1 December 2017

215-216

1 reference

Primary progressive multiple sclerosis

1 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900350-7

Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900350-7

Cladribine and progressive MS: Clinical and MRI outcomes of a multicenter controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900350-7

Intravenous immunoglobulin (IVIG) treatment for patients with primary or secondary progressive multiple sclerosis -- outline of a double-blind randomized, placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900350-7

Interferon beta-1a in primary progressive MS: an exploratory, randomized, controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900350-7

The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900350-7

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900350-7

10.1016/S0022-510X(02)00350-7

7 January 2021

Identifiers

DOI

1 reference

1 December 2017

1 reference

PubMed ID

12559514